IAH0968
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for IAH0968, covering 2024-02-20 to 2025-01-20. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer [Phase 2, Phase 3]